Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development-endpointnews: FDA commissioner Scott Gottlieb has sounded a crystal clear warning over the high — and growing — cost of drug development. And in a speech to regulatory execs on Monday, Gottlieb committed the FDA to backing up more efficient drug development programs with new measures to clear the regulatory path for developers barreling ahead to relatively swift pivotal data in search of an accelerated OK.